Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GS202
- Development stage
- Preclinical
- Lead developer
- Jiangsu Genscend Biopharmaceutical
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
GS202 is a preclinical-stage bispecific monoclonal antibody being developed by Genscend Biopharmaceutical as a biosimilar/biobetter of amivantamab (Rybrevant). It is designed to target both the epidermal growth factor receptor (EGFR) and the hepatocyte growth factor receptor (c-Met). By binding to these two receptors, GS202 is intended to inhibit downstream receptor signaling and promote immune-mediated tumor-cell killing, offering a potential therapeutic option for oncology indications, particularly EGFR-mutated non-small cell lung cancer (NSCLC) and other EGFR/c-Met-driven malignancies.
- Other names
- Amivantamab biosimilarAmivantamab-VMJM biosimilar
02
Targets
EGFR (Epidermal growth factor receptor)MET (Mesenchymal-epithelial transition factor receptor)
Beyond the preview
Go deeper on GS202.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GS202.